Abstract: A lamination apparatus for a secondary battery, which thermally bonds an electrode assembly in which electrodes and separators are alternately stacked, the lamination apparatus comprising: a transfer member to transfer the electrode assembly; a support member to support each of top and bottom surfaces of the electrode assembly transferred by the transfer member; a heating member disposed outside the support member to heat the electrode assembly supported by the support member; and a moving member to move the heating member in a direction away from the electrode assembly. The moving member moves the heating member in the direction away from the electrode assembly to prevent the electrode assembly from being heated by the heating member when the transfer member is stopped.

Abstract: The present invention relates to a use of CD133 involved in resistance to an EGFR-targeting agent in colon cancer. The CD133 protein may be used as a novel target protein for diagnosing and treating resistant cancer as well as general cancer.

Abstract: The present invention relates to a use of CD133 involved in resistance to an EGFR-targeting agent in colon cancer. The CD133 protein may be used as a novel target protein for diagnosing and treating resistant cancer as well as general cancer.

Abstract: A lamination apparatus for a secondary battery, which thermally bonds an electrode assembly in which electrodes and separators are alternately stacked, the lamination apparatus comprising: a transfer member to transfer the electrode assembly; a support member to support each of top and bottom surfaces of the electrode assembly transferred by the transfer member; a heating member disposed outside the support member to heat the electrode assembly supported by the support member; and a moving member to move the heating member in a direction away from the electrode assembly. The moving member moves the heating member in the direction away from the electrode assembly to prevent the electrode assembly from being heated by the heating member when the transfer member is stopped.

Abstract: The present invention relates to a lamination apparatus for a secondary battery, which thermally bonds an electrode assembly in which electrodes and separators are alternately stacked, the lamination apparatus comprising: a transfer member to transfer the electrode assembly; a support member to support each of top and bottom surfaces of the electrode assembly transferred by the transfer member; a heating member disposed outside the support member to heat the electrode assembly supported by the support member; and a moving member to move the heating member in a direction away from the electrode assembly.

Abstract: A voice transmitter assembly for enhancing verbal communication for a user wearing a face mask includes a clip that has a first member which is biased against a second member to engage a face mask. A microphone is coupled to the second member of the clip to capture words spoken by the user. A speaker is coupled to the first member of the clip to emit audible sounds to a listener. The speaker is in communication with the microphone thereby facilitating the speaker to emit sounds captured by the microphone. In this way the speaker can enhance the listener's ability to hear the words spoken by the user.

Abstract: A voice transmitter assembly for enhancing verbal communication for a user wearing a face mask includes a clip that has a first member which is biased against a second member to engage a face mask. A microphone is coupled to the second member of the clip to capture words spoken by the user. A speaker is coupled to the first member of the clip to emit audible sounds to a listener. The speaker is in communication with the microphone thereby facilitating the speaker to emit sounds captured by the microphone. In this way the speaker can enhance the listener's ability to hear the words spoken by the user.

Abstract: The present invention relates to a secondary battery. The secondary battery comprises: an electrode assembly having a through-hole; and a battery case accommodating the electrode assembly and having a through-type opening into which the through-hole is inserted, wherein the battery case comprises: a lower case comprising an accommodation part accommodating the electrode assembly and a lower inner sealing part having the through-type opening into which the through-hole is inserted; and an upper case comprising a cover part coupled to an upper portion of the lower case to finish the accommodation part and an upper inner sealing part having a coupling hole to which a front end of the lower inner sealing part is coupled.

Abstract: The present invention relates to a nasolacrimal duct insertion member comprising a shape memory polymer for treatment of nasolacrimal duct obstruction/stenosis, wherein the shape memory polymer comprises a crosslinkable functional group, such that the nasolacrimal duct insertion member has a melting point suitable for implantation into a living body.

Abstract: The present invention relates to a pharmaceutical use of actinin-4 involved in the induction of cervical cancer, and more specifically, characterizes actinin-4 as a marker protein capable of inducing cervical cancer, thereby providing the pharmaceutical use of actinin-4 that can be used in the diagnosis, prevention or treatment of cervical cancer.

Abstract: The present invention relates to a use of CD133 involved in resistance to an EGFR-targeting agent in colon cancer. The CD133 protein may be used as a novel target protein for diagnosing and treating resistant cancer as well as general cancer.

Abstract: The present invention relates to a secondary battery. The secondary battery comprises: an electrode assembly having a through-hole; and a battery case accommodating the electrode assembly and having a through-type opening into which the through-hole is inserted, wherein the battery case comprises: a lower case comprising an accommodation part accommodating the electrode assembly and a lower inner sealing part having the through-type opening into which the through-hole is inserted; and an upper case comprising a cover part coupled to an upper portion of the lower case to finish the accommodation part and an upper inner sealing part having a coupling hole to which a front end of the lower inner sealing part is coupled.

Abstract: The present invention relates to a secondary battery. The secondary battery comprises: an electrode assembly having a through-hole; and a battery case accommodating the electrode assembly and having a through-type opening into which the through-hole is inserted, wherein the battery case comprises: a lower case comprising an accommodation part accommodating the electrode assembly and a lower inner sealing part having the through-type opening into which the through-hole is inserted; and an upper case comprising a cover part coupled to an upper portion of the lower case to finish the accommodation part and an upper inner sealing part having a coupling hole to which a front end of the lower inner sealing part is coupled.

Abstract: The present invention relates to a lamination apparatus for a secondary battery, which thermally bonds an electrode assembly in which electrodes and separators are alternately stacked, the lamination apparatus comprising: a transfer member to transfer the electrode assembly; a support member to support each of top and bottom surfaces of the electrode assembly transferred by the transfer member; a heating member disposed outside the support member to heat the electrode assembly supported by the support member; and a moving member to move the heating member in a direction away from the electrode assembly.

Abstract: The present invention relates to a use of a human small leucine zipper protein in the osteogenesis procedure. More specifically, sLZIP increases the transcriptional activity of Runx2 and inhibits the transcriptional activity of PPAR?2, thereby increasing the osteoblast differentiation, so that sLZIP performs an important role in the osteogenesis procedure, and thus can be used as a marker for treating bone disease and developing new medicines.

Abstract: The present invention provides an electronic device having a flexible display panel wherein a user can easily fold or unfold a plurality of unit bodies to expand or contract the display area of the flexible display panel, and when the unit bodies are folded, a portion of the flexible display panel is received in the hollow unit body.

Abstract: An electronic device including: a first functional panel having a photovoltaic cell panel defined as an upper portion thereof; a second functional panel having a display panel defined as an upper portion thereof; and a linking mechanism for connecting the first functional panel and the second functional panel to each other. A mutual-orientation between the first functional panel and the second functional panel is switched between a plurality of mutual-orientations via the linking mechanism.

Abstract: The present invention relates to a secondary battery. The secondary battery comprises: an electrode assembly having a through-hole; and a battery case accommodating the electrode assembly and having a through-type opening into which the through-hole is inserted, wherein the battery case comprises: a lower case comprising an accommodation part accommodating the electrode assembly and a lower inner sealing part having the through-type opening into which the through-hole is inserted; and an upper case comprising a cover part coupled to an upper portion of the lower case to finish the accommodation part and an upper inner sealing part having a coupling hole to which a front end of the lower inner sealing part is coupled.

Abstract: The present invention relates to a use of a human small leucine zipper protein in the adipocyte differentiation procedure. More specifically, sLZIP binds with PPAR?2 to induce the formation of a complex of HDAC3 and PPAR?2, thereby functioning as a corepressor to negatively inhibit the transcriptional activity of PPAR?2 and suppress the differentiation to adipocytes, and thus can be used as a marker for treating diabetes and obesity and developing new medicines therefor.

Abstract: A bearing steel includes 1.0 to 1.3 wt % carbon; 0.9 to 1.6 wt % silicon; 0.5 to 1.0 wt % manganese; 1.5 to 2.5 wt % nickel; 1.5 to 2.5 wt % chromium; 0.2 to 0.5 wt % molybdenum; 0.01 to 0.06 wt % aluminum; 0.01 to 0.1 wt % copper; at least one selected from the group consisting of more than 0 wt % and less than 0.38 wt % vanadium and more than 0 wt % and less than 0.02 wt % niobium; and a balance of iron.